Overview

Global Smart Insulin Pens Market is estimated to value over USD 113 million by 2026 end and register a CAGR of over 10.5% during the forecast period 2019 to 2026.

A rise in the presence of diabetic conditions raises the insistence for needle-free insulin delivery devices that are needle-free. As per the Centers for Disease Control and Prevention (CDC), approximately 30 million people or over 9% of the total population of the United States suffered from diabetes in 2015. Additionally, as per the Diabetes UK, in 2017, over 3.2 million people were diabetes patients. Therefore, an increase in diabetes-related conditions is projected to have a positive influence on the smart insulin pens market growth.

The Asia Pacific market is predicted to expand the smart insulin pens market size with a high growth rate over the forecast period, owing to a rise in the ageing population who have more chances of getting diagnosed with diabetes. The Asia-Pacific region offers profitable opportunities for market proliferation, owing to its ever-increasing population base and increase in the prevalence of diabetic patients. Additionally, low device costs as compared to traditional insulin pen shall further increase the insistence of smart insulin pens in the Asia Pacific region.

 

Key market players included in smart insulin pens industry are Novo Nordisk, Sanofi, Eli Lilly and Co., Companion Medical, Emperra GmbH E-Health Technologies, Diabnext, Jiangsu Delfu Medical Device Co. Ltd., Berlin Chemie, Diamesco Co. Ltd., Patients Pending Ltd. 

 

Smart Insulin Pens Market Segmentation:

By Product

  • Smart Insulin Pen
  • Adaptors for Conventional Pen

By Connectivity

  • Bluetooth
  • USB

By Diabetes Type

  • Type 1 Diabetes
  • Type 2 Diabetes

By Distribution Channel

  • Hospital Pharmacy
  • Online Sales
  • Retail Pharmacy
  • Diabetes Clinics/Centres

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

 

FutureWise Key Takeaways:

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

 

Objectives of the Study:

  • To provide with an exhaustive analysis on the smart insulin pens market by product, by connectivity, by diabetes type, by distribution channel and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, industry-specific restraints and opportunities)
  • To forecast and evaluate micro-markets and the overall market 
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East & Africa
  • To record, evaluate and analyse competitive landscape mapping- technological advancements, product launches, expansions and mergers

$3450

Need Assistance

--------

UK : +44 141 628 9353
US : +1 347 709 4931

OR

Contact Sales

What you get


  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included


  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics